Results 321 to 330 of about 869,733 (343)

Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variants. [PDF]

Protein Sci
Hino N, Takada R, Suzuki K, Tokunoh N, Karaki T, Ohtake K, Ogami H, Nishiura T, Ishimoto K, Tsukamoto T, Ago Y, Okada Y, Okamoto T, Ono C, Matsuura Y, Obika S, Sakamoto K, Yoshioka Y, Nakagawa S.   +18 more
europepmc   +1 more source

Advancing Energy and Indoor Environmental Quality Through Integrated Co‐Simulation and Multi‐Objective Optimisation for SARS‐CoV‐2 Risk Mitigation: A UK Case Study

Energy Science &Engineering, EarlyView.
ABSTRACT In today's modern world, people spend most of their time indoors, making indoor air quality (IAQ) a critical concern, particularly in educational buildings, where densely occupied classrooms demand clean and healthy environments. This study enhances the IAQ of an existing college building in West London by aiming to reduce carbon dioxide (CO2)
Atefeh Abbaspour, Ali Bahadori‐Jahromi, Alan Janbey, Hooman Tahayori   +3 more
wiley   +1 more source

Cholesterol in viral envelope determines infectivity of SARS-CoV-2 and other coronaviruses. [PDF]

Front Microbiol
Xu X, Wang X, Zhang X, Jin X, Tan Y, Huang L, Zhou M, Wen C.   +7 more
europepmc   +1 more source

Single‐Cell Transcriptomic Analysis of the Immune Response to COVID‐19 and Tuberculosis Coinfection

Exploration, EarlyView.
Understanding the immunological basis for severe outcomes in COVID‐19/Tuberculosis coinfection is critical. Our single‐cell analysis identifies key drivers: profound lymphocyte loss through combined apoptosis and altered trafficking, excessive S100 protein‐mediated inflammation contributing to cytokine storms, and systemic immune dysfunction ...
Yi Wang, Maike Zheng, Yun Zhang, Yu Xue, Sibo Long, Chaohong Wang, Qing Sun, Jun Yan, Yiheng Shi, Bin Yang, Shang Ma, Tiantian Zhang, Lei Cao, Yan Chen, Wenfu Ju, Jing Zhang, Yan Zhao, Mengqiu Gao, Laurence Don Wai Luu, Xinting Yang, Guirong Wang   +20 more
wiley   +1 more source

Reduction of extracellular vimentin in blood provides protection against SARS-CoV-2 infection. [PDF]

Virulence
Kim HM, Wang M, Zhai C, Kim S, Park J, Hong ST.   +5 more
europepmc   +1 more source

Development of a Promising Bivalent Vaccine Against Klebsiella pneumoniae Based on Glycoengineered GMMA (geGMMA)

Exploration, EarlyView.
Multidrug‐resistant Klebsiella pneumoniae poses a significant threat as a nosocomial pathogen, with no current licensed vaccines available. This study used a mutant E. coli strain expressing exogenous polysaccharides (from K. pneumoniae) to establish glycoengineered generalized modules for membrane antigens (geGMMA) vaccine platform, which demonstrated
Jingqin Ye, Wenhua Huang, Shujuan Yu, Yan Guo, Peng Sun, Ziyuan Chen, Linhui Hao, Yan Zhang, Caixia Li, Yongqiang Jiang, Jun Wu, Li Zhu, Hengliang Wang, Chao Pan   +13 more
wiley   +1 more source

SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient. [PDF]

Nat Commun
Fuchs J, Karl V, Hettich I, Alvarado J, Eckert D, Jaki L, Kohl AK, Kremser A, Maks A, Terschluse C, Agarwal P, Emmerich F, Fähndrich S, Flügler A, Hornuss D, Kalbhenn J, Kneidinger N, Lau I, Lother A, Moneke I, Schibilsky D, Schygulla E, Venhoff N, Zissel G, Czerny M, Huzly D, Kochs G, Neumann-Haefelin C, Passlick B, Stolz D, Thimme R, Panning M, Hofmann M, Frye BC.   +33 more
europepmc   +1 more source

The Cerebral Haemorrhage and SARS-CoV-2: An Emerging Virus From a Meta-Analysis Perspective. [PDF]

Rev Med Virol
Wang Y, Zhang C, Zhang Y, Zhang Z.
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

Pneumothorax and Pneumomediastinum in SARS-CoV-2 Infection. [PDF]

Medicina (Kaunas)
Aldea C, Abdulan IM, Ciuntu BM, Negru R, Luca CM.   +4 more
europepmc   +1 more source